Want to join the conversation?
$CYNO said it got approval from Korean Ministry of Food and Drug Safety (MFDS) to market SculpSure for non-invasive lipolysis of abdomen and flanks. The product will be marketed through its direct sales force in Korea beginning in 3Q16. SculpSure is effective non-invasive treatment that eliminates up to 24% of treated fat in 25-minute procedure.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?